Marie Yasuda, PharmD, MS

IQVIA

Disclosure(s): Amgen: Grant/Research Support; Bayer: Grant/Research Support; BMS: Grant/Research Support; GSK: Advisor/Consultant; Novartis: Grant/Research Support; Sandoz: Grant/Research Support; Servier: Grant/Research Support

Poster(s):

• (P-29) Recombinant Zoster Vaccine Uptake Among Immunocompromised US Adults
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-36) RSV Vaccination Uptake Among US Adults Aged ≥60 Years Who Are at Increased Risk of Severe RSV Disease (August 2023-February 2024)
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT